These recommendations from EULAR provide consensus and up-to-date guidance on fatigue management in people with I-RMDs, which includes advice regarding pharmacological and non-pharmacological interventions.

A multidisciplinary taskforce comprising 26 clinicians, academics, methodologists and experts from 14 European countries was convened, and two systematic reviews were conducted. The reviews and the taskforce members’ experience of fatigue in I-RMDs were used as the basis for the recommendations.

Keywords:


Publication thumbnail: 2023 EULAR Recommendations for the Management of Fatigue in People with Inflammatory Rheumatic and Musculoskeletal Diseases
LinkedIn